View in EDS

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.

Saved in:
Bibliographic Details
Title: Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.
Authors: Schwarz M; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Schwarz C; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Schütz A; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Schwanke C; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Krabb E; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Schubert R; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Liebich ST; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Bauer D; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Burghart L; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Brinkmann L; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Gutic E; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria., Reiberger T; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Haltmayer H; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Gschwantler M; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Sigmund Freud University, Vienna, Austria.
Source: Journal of virus eradication [J Virus Erad] 2023 Mar 02; Vol. 9 (1), pp. 100319. Date of Electronic Publication: 2023 Mar 02 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101654142 Publication Model: eCollection Cited Medium: Print ISSN: 2055-6640 (Print) Linking ISSN: 20556640 NLM ISO Abbreviation: J Virus Erad Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36970063
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schwarz+M%22">Schwarz M</searchLink>; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Schwarz+C%22">Schwarz C</searchLink>; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Schütz+A%22">Schütz A</searchLink>; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Schwanke+C%22">Schwanke C</searchLink>; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Krabb+E%22">Krabb E</searchLink>; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Schubert+R%22">Schubert R</searchLink>; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Liebich+ST%22">Liebich ST</searchLink>; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Bauer+D%22">Bauer D</searchLink>; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Burghart+L%22">Burghart L</searchLink>; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Brinkmann+L%22">Brinkmann L</searchLink>; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Gutic+E%22">Gutic E</searchLink>; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Reiberger+T%22">Reiberger T</searchLink>; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Haltmayer+H%22">Haltmayer H</searchLink>; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Gschwantler+M%22">Gschwantler M</searchLink>; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Sigmund Freud University, Vienna, Austria.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101654142%22">Journal of virus eradication</searchLink> [J Virus Erad] 2023 Mar 02; Vol. 9 (1), pp. 100319. <i>Date of Electronic Publication: </i>2023 Mar 02 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101654142 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2055-6640 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220556640%22">20556640 </searchLink><i>NLM ISO Abbreviation: </i>J Virus Erad <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36970063
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jve.2023.100319
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100319
    Titles:
      – TitleFull: Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schwarz M
      – PersonEntity:
          Name:
            NameFull: Schwarz C
      – PersonEntity:
          Name:
            NameFull: Schütz A
      – PersonEntity:
          Name:
            NameFull: Schwanke C
      – PersonEntity:
          Name:
            NameFull: Krabb E
      – PersonEntity:
          Name:
            NameFull: Schubert R
      – PersonEntity:
          Name:
            NameFull: Liebich ST
      – PersonEntity:
          Name:
            NameFull: Bauer D
      – PersonEntity:
          Name:
            NameFull: Burghart L
      – PersonEntity:
          Name:
            NameFull: Brinkmann L
      – PersonEntity:
          Name:
            NameFull: Gutic E
      – PersonEntity:
          Name:
            NameFull: Reiberger T
      – PersonEntity:
          Name:
            NameFull: Haltmayer H
      – PersonEntity:
          Name:
            NameFull: Gschwantler M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 03
              Text: 2023 Mar 02
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2055-6640
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of virus eradication
              Type: main
ResultId 1